Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 1272 for “"hepatitis-c"”.
-
Einfluss von Immunsuppression auf Hepatitis C-assoziierte Immunphänomene und Hepatitis C-Quasispezies
Eine chronische Hepatitis C Infektion geht mit vielfältigen Autoimmunphänomenen einher. Deren klinische Bedeutung, sowie die Auswirkungen der HCV-assoziierten Kryoglobulinämie und der Komplementaktivierung auf die Transplantatfunktion bei nierentransplantierten Patienten wurden in dieser Arbeit …
-
"Constructing" Hepatitis C in Philadelphia
This research explores how the CDC Hepatitis Epidemiology Investigation Team at the Philadelphia Department of Public Health (PDPH) constructs Hepatitis C (HCV) in the public and medical discourse through their monitoring and education activities. Data in the form of field notes and ethnographic …
-
Hepatitis C Virus in Saliva
To investigate the prevalence of hepatitis C virus in saliva, the saliva of a group of haemophiliacs and blood donors, who were previously shown to be anti HCV positive by second generation immunoassay and a recombinant immunoblot, was examined using reverse transcription and the polymerase chain …
-
Hepatitis C and Ribavirin. Focus on Ribavirin as an important component in hepatitis C treatment
Radboud Universiteit Nijmegen, 07 januari 2011
-
Experiences of injecting drugs, alcohol use and hepatitis C in Merseyside: Barriers to hepatitis C support
Hepatitis C is a blood borne virus affecting the liver. In the UK, approximately 214,000 people are infected with the hepatitis C virus. Hepatitis C disproportionally affects marginalised populations and in the UK sharing equipment used to inject drugs is the main risk factor for hepatitis C …
-
Infection dynamics of Hepatitis C virus
… sought to identify infection with more than one hepatitis C virus (HCV). Longitudinal sera were collected from participants in two prospective cohorts of HCV infected patients. The Hepatitis C Incidence and Transmission Study (HITS) is cohort of HCV seronegative/RNA negative, high risk imprisoned …
-
Human dendritic cells and hepatitis C Virus
… used as therapeutic tools or vaccine carriers. Hepatitis C virus (HCV) is a hepatotropic virus, which infects the liver in humans and results in a chronic infection in most cases. The persistent infection of the liver eventually results in cirrhosis and/or hepatocellular carcinoma in 15-20 …
-
Investigating mechanisms of Hepatitis C virus endocytosis
… more than one pathway implicated in some cases. Hepatitis C virus (HCV) is a hepatotropic virus associated with liver disease, fibrosis, cirrhosis and hepatocellular carcinoma. There are four co-receptors or “entry factors” for HCV: the tetraspanin CD81, scavenger receptor BI (SR-BI and the tight …
-
HEPATITIS C: PATHWAYS FOR DIAGNOSIS AND TREATMENT
Scotland has committed to eradicating Hepatitis C (HCV) by 2030. In order to achieve this goal, rates of HCV diagnosis, treatment and cure need to be escalated. Given that those most at risk of HCV infection e.g. people who inject drugs (PWID) often belong to a marginalised part of society and find …
-
Selecting a path against Hepatitis C Virus
Hepatitis C virus (HCV) currently affects ~5% of the world’s population and has relatively limited treatment options for infected patients. Genetic suppressor elements (GSE) derived from a gene or genome of interest can act as transdominant inhibitors of a particular biology function presumably by …
-
Small molecule effects on Hepatitis C Virus
… chemical biology approaches were used to study Hepatitis C Virus (HCV) in non-infectious, subgenomic HCV replicon model systems. Specifically, small molecules were used as probes for studying host-virus interactions. Compared to genetic techniques, small molecules are interesting potential …
-
Implementation of a Hepatitis C Screening Protocol
Hepatitis C remains a chronic health condition in the United States and represents a major factor in the development of hepatocellular cancer. Despite the introduction of newly developed antiviral medications, many of those infected with chronic hepatitis C remain undiagnosed and untreated. This …
-
Primary hepatitis C virus infection in prisons
Infection with hepatitis C virus (HCV) causes significant morbidity and mortality. An understanding of the factors associated with both acquisition and clearance of HCV infection is critical to prevention strategies including vaccine development. Although research in the prison environment is …
-
Aptamers to the hepatitis C virus polymerase
Treatments for the hepatitis C virus (HCV) are currently only partially effective. Research into antivirals directed at HCV viral proteins are commonly based and tested on a single genotype, namely genotype 1. This is despite the high level of variability of the RNA virus and the frequency of …
-
Molecular evolution of hepatitis C virus quasispecies.
The viral dynamics of the hepatitis C virus (HCV) in newly acquired infection are not well understood. HCV exists within an individual as a spectrum of minor variants termed quasispecies. The evolution of minor variants may contribute to viral escape of the host?s immune response, thereby …
-
Protective immunity in hepatitis C virus infection
Primary hepatitis C virus (HCV) HCV infection is associated with viraemia which induces cellular and humoral immune responses in the majority of individuals, regardless of subsequent outcome. HCV-specific immune responses have also been documented in subjects who appear to have never had infection, …
-
A pharmacist’s contribution to eradicate hepatitis C.
Contains fulltext : 173898.pdf (Publisher’s version ) (Open Access)
-
Determinants of hepatitis C virus clinical outcomes
Hepatitis C VIruS (HCY) infection is characterized by a broad spectrum of clinical outcomes. An estimated 14%-46% of individuals exposed to HCY are able to clear the virus, while the other portion develops chronic (persistent) infections. Among the individuals with chronic HCY who are treated with …
-
Micro-elimination of chronic hepatitis C in lost to follow-up patients. The road to nationwide hepatitis C elimination
Radboud University, 17 mei 2023
Page 1 of 64